Detalhe da pesquisa
1.
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Cell
; 176(3): 564-580.e19, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580964
2.
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling.
Genes Dev
; 34(7-8): 526-543, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079652
3.
The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.
Trends Biochem Sci
; 41(12): 1022-1034, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27669647
4.
p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities.
Mol Cancer Res
; 19(9): 1522-1533, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34045312
5.
Dysfunction of the MDM2/p53 axis is linked to premature aging.
J Clin Invest
; 127(10): 3598-3608, 2017 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28846075
6.
Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations.
Virology
; 387(2): 364-72, 2009 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19327810